Insider Transactions in Q2 2025 at 10x Genomics, Inc. (TXG)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2025
|
Serge Saxonov Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.1%
|
-
|
|
Jun 03
2025
|
Sarah A. Teichmann |
BUY
Grant, award, or other acquisition
|
Direct |
15,357
+30.89%
|
-
|
|
Jun 03
2025
|
Sridhar Kosaraju |
BUY
Grant, award, or other acquisition
|
Direct |
15,357
+21.39%
|
-
|
|
Jun 03
2025
|
Alan Mateo |
BUY
Grant, award, or other acquisition
|
Direct |
15,357
+16.62%
|
-
|
|
Jun 03
2025
|
Kimberly J Popovits |
BUY
Grant, award, or other acquisition
|
Direct |
15,357
+34.92%
|
-
|
|
Jun 03
2025
|
John R Stuelpnagel |
BUY
Grant, award, or other acquisition
|
Direct |
15,357
+4.1%
|
-
|
|
Jun 03
2025
|
Shehnaaz Suliman |
BUY
Grant, award, or other acquisition
|
Direct |
15,357
+34.92%
|
-
|
|
May 29
2025
|
Serge Saxonov Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.28%
|
-
|
|
May 22
2025
|
Adam Taich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,044
-1.2%
|
$32,352
$8.3 P/Share
|
|
May 22
2025
|
Benjamin J. Hindson |
SELL
Open market or private sale
|
Direct |
7,485
-1.64%
|
$59,880
$8.3 P/Share
|
|
May 22
2025
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,343
-0.85%
|
$74,744
$8.3 P/Share
|